Kits Eyecare Ltd.
KITS.TO · TSX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.36 | 1.67 | 0.27 | -0.06 |
| FCF Yield | 3.72% | 0.94% | 5.27% | -25.56% |
| EV / EBITDA | 31.16 | 105.09 | -117.15 | -6.51 |
| Quality | ||||
| ROIC | 5.39% | -2.73% | -4.61% | -17.01% |
| Gross Margin | 33.67% | 33.85% | 31.92% | 25.35% |
| Cash Conversion Ratio | 4.18 | -1.09 | -1.03 | 1.33 |
| Growth | ||||
| Revenue 3-Year CAGR | 20.25% | 13.51% | 6.80% | 30.71% |
| Free Cash Flow Growth | 436.54% | -58.32% | 119.13% | -683.62% |
| Safety | ||||
| Net Debt / EBITDA | -0.80 | -0.35 | -0.90 | -0.17 |
| Interest Coverage | 3.49 | -1.53 | -2.67 | -7.70 |
| Efficiency | ||||
| Inventory Turnover | 4.70 | 5.17 | 3.80 | 4.56 |
| Cash Conversion Cycle | 8.06 | 16.99 | 15.05 | 34.21 |